Eutylone is a stimulant and empathogenic compound

Eutylone is a stimulant and empathogenic compound developed in the 1960s, which is classified as a designer drug. It was first reported to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in 2014, marking its entry into the regulatory landscape. Following this initial report, Eutylone gained significant traction and became widespread internationally in 2019-2020. This surge in popularity can be attributed to the bans imposed on related compounds, particularly ephylone, which led users and manufacturers to seek alternatives that could provide similar effects. Eutylone is not a natural substance; rather, it is classified as a synthetic cathinone, a category of drugs that are chemically similar to cathinone, a stimulant found in the khat plant.